ライフサイエンスコーパス: biochemical marker

1 K(i-PAT) was equivalent to that observed for biochemical markers.

2 mulation of lipids and expression of several biochemical markers.

3 inical presentation and measurement of other biochemical markers.

4 yndromes in the setting of new therapies and biochemical markers.

5 women aged 50-65 y was evaluated with use of biochemical markers.

6 examination, including body composition and biochemical markers.

7 eg) and analyzed using neuropathological and biochemical markers.

8 aneously, which was proved by enhanced serum biochemical markers.

9 ent whether FGR was defined by ultrasound or biochemical markers.

10 everses or protects against LIDs and its key biochemical markers.

11 served as respective physical, molecular and biochemical markers.

12 and inflammation alongside hematological and biochemical markers.

13 models using patient history, ultrasound and biochemical markers.

14 correlation between SUVmax of the tumors and biochemical markers.

15 ne and 6-mo values for the PET parameters or biochemical markers.

16 determines the period length of a circadian biochemical marker (60 X the ECTO-NOX period length) pro

17 t and osteoclast development, decreased bone biochemical markers, a diminished bone formation rate an

18 patients demonstrated resolution of abnormal biochemical markers after ablation (mean biochemical fol

19 However, no relationship between a reliable biochemical marker and increased severity of the periodo

20 culated to determine the association between biochemical markers and a range of imaging features from

21 IPD analysis) to assess associations between biochemical markers and adverse outcomes using logistic

22 sorption in TPH(1)(-/-) mice, as assessed by biochemical markers and bone histomorphometry, was marke

23 turnover and bone quality were assessed with biochemical markers and bone histomorphometry.

24 sed neural networks may be an alternative to biochemical markers and clinical scoring systems.

25 improved, and the high correlations between biochemical markers and estimates from weighed-food reco

26 diation-induced G(2) arrest as shown by both biochemical markers and fluorescence-activated cell sort

27 This combination of biochemical markers and imaging methodology will also us

28 nge (ADNC), we analysed associations between biochemical markers and mediators of cerebral hypoperfus

29 ine the relationship between the fundamental biochemical markers and neurological outcome in a large

30 iological, molecular, genetic, endocrine and biochemical markers and optimization of pulsatile admini

31 determine the association between individual biochemical markers and radiographic features, and to es

32 d to further explore the association between biochemical markers and survival.

33 chanisms of estrogen receptor transcription, biochemical markers and therapeutic targets in breast ca

34 Biochemical markers and tissue biopsy, which have tradit

35 was assessed by anthropometric measurements, biochemical markers, and a Mini Nutritional Assessment (

36 nges, aspects of the clinical history, newer biochemical markers, and angiographic findings help to b

37 general nutritional status (dietary intake, biochemical markers, and anthropometric measurements) in

38 s the relationship between body composition, biochemical markers, and retinal microvascular changes i

39 body composition, strength, quality of life, biochemical markers, and safety in patients with cancer

40 Biochemical markers are available to detect cardiac invo

41 he association is strengthened when selected biochemical markers are combined into a single factor (a

42 ) is based on imaging criteria, and specific biochemical markers are not available.

43 These results indicate that biochemical markers are useful predictors of radiographi

44 hanical therapy did not significantly reduce biochemical markers associated with bone resorption in p

45 umber of workdays lost; genetic and baseline biochemical markers associated with symptomatic COVID-19

46 mes included anthropometric measurements and biochemical markers at 6, 12, 24, 36, and 48 months post

47 d in relation to clinical, neuroimaging, and biochemical markers at inclusion and follow-up.

48 oderate decline in BMD and a gradual rise in biochemical markers but no higher fracture risk other th

49 nd thiamethoxam altered food consumption and biochemical markers, but effects were less severe than f

50 31P-MRS abnormalities may offer a surrogate biochemical marker by which to study disease progression

51 Biochemical markers can also help in screening patients

52 calization studies revealed multiple foci of biochemical markers characteristic of active centromeres

53 ore, rescued sensory neurons fail to express biochemical markers characteristic of the nociceptive ph

54 In a model including both biochemical markers, CK-MB added no predictive informati

55 The PCA results suggest that biochemical marker combinations may be more sensitive th

56 RECENT FINDINGS: The biochemical markers currently under evaluation include a

57 Biochemical markers demonstrating a significant associat

58 y relevant differences in anthropometric and biochemical markers depending on sex and age were found.

59 Also, biochemical markers did not correlate with the scan find

60 enoid side chains of the membrane lipids are biochemical markers distinguishing archaea from the rest

61 aman microspectroscopy was used to determine biochemical markers during the differentiation of embryo

62 Changes in biochemical markers during year 3 did not differ among t

63 Integration of metagenomic findings with biochemical markers (e.g. , GGT: OR 0.79, p = 0.03) furt

64 erformance and was significantly superior to biochemical markers (e.g., aspartate aminotransferase [A

65 GRS was not consistently associated with any biochemical marker except for uric acid, arguing against

66 senescence-associated beta-galactosidase (a biochemical marker for cellular senescence), and reducti

67 not frequently measured, is the most robust biochemical marker for diagnosing 11beta-hydroxylase def

68 lebrand factor (vWF) is frequently used as a biochemical marker for endothelial cells (ECs).

69 aspiration and may prove a clinically useful biochemical marker for episodes of occult pulmonary aspi

70 ymosin beta 15 may represent a potential new biochemical marker for human prostate cancer progression

71 bunit phosphorylation at Ser-831 is an early biochemical marker for long-term potentiation and learni

72 tein specific to the human type I cell, is a biochemical marker for lung injury.

73 ne content of released cytosolic proteins, a biochemical marker for PN formation.

74 s in the cyclic AMP-PKA signaling pathway, a biochemical marker for psoriasis, may offer some mechani

75 Thus, the reporter protein provides a biochemical marker for studying protein traffic through

76 crotubule-associated protein and providing a biochemical marker for the induction of autophagy.

77 n bovine prothrombin may constitute a useful biochemical marker for the membrane-binding conformation

78 s that urinary DES excretion may be a useful biochemical marker for the study of interventions design

79 ular fractionation, Atx2p colocalized with a biochemical marker for the yeast Golgi apparatus.

80 n injury as evaluated by cerebrospinal fluid biochemical markers for axonal damage and other aspects

81 ations may be more sensitive than individual biochemical markers for reflecting structural damage in

82 the activities of enzymes used as surrogate biochemical markers for T2 diabetes and inflammation.

83 prognostic markers, therapeutic targets, and biochemical markers for targeted enrollment in therapeut

84 -1 (ET-1) release were monitored as specific biochemical markers for temporal gradients and endotheli

85 as a novel approach that provides intrinsic biochemical markers for the noninvasive detection of ind

86 In conclusion, serum metabolite levels and biochemical markers from a single blood sample possess m

87 Biochemical markers harvested from gingival crevicular f

88 ctional immunologic and platelet assays, and biochemical markers has allowed for more in-depth evalua

89 ever increasing number of optically reactive biochemical markers has become available, which allow di

90 Several biochemical markers have been investigated for the nonin

91 Although biochemical markers have been widely used, intrinsic bio

92 Biochemical markers have not been routinely used in chil

93 Biochemical markers have the potential to act as adjunct

94 d extent of liver injury was evaluated using biochemical markers, histological staining, and immunofl

95 the most improvement in comparison with the biochemical markers; however, the correlations of crude

96 Levels of a variety of biochemical markers, i.e., MMP-3, CTX-II, COMP, TIMP-1,

97 Biochemical markers identifying patients with osteophyte

98 clude that CSF LCN2 is a promising candidate biochemical marker in the differential diagnosis of VaD

99 ion via dynamic, noninvasive measurements of biochemical markers in biofluids, such as sweat, tears,

100 (such as of magnetic resonance imaging) and biochemical markers in body fluid.

101 an noninvasively and continuously screen for biochemical markers in body fluids for the prognosis, di

102 d the relative tumor concentrations of these biochemical markers in children with recurrent brain tum

103 of organ dysfunction, 28-day mortality, and biochemical markers in children with thrombocytopenia-as

104 s in comparison with weighed-food records or biochemical markers in either the total group of subject

105 The studies in the past year involving biochemical markers in humans can be assigned to one of

106 ehaviors indicative of persistent pain, with biochemical markers in the spinal cord dorsal horn and s

107 ve technique for spatial characterization of biochemical markers in tissues.

108 Biochemical markers, including lipid profile, liver func

109 Measurement of bone turnover done by using biochemical markers is a promising new diagnostic method

110 suitable for quantitative evaluation of all biochemical markers is of great advance over conventiona

111 sociation with the concentration of specific biochemical markers is unclear.

112 rom nonsmall cell lung cancer is evolving as biochemical markers may be used to guide the treatment o

113 These biochemical markers may play a role in directing treatme

114 eart has been associated with the release of biochemical markers (natriuretic peptides and cardiac en

115 of cardiac troponin complexes and a pivotal biochemical marker of acute myocardial infarction (AMI).

116 Surprisingly, serum osteocalcin levels, a biochemical marker of bone formation, suggested that the

117 ntation, despite a significant increase in a biochemical marker of bone resorption in the calcitriol

118 A multiple-regression model using a biochemical marker of bone turnover (serum osteocalcin)

119 triuretic factor message, a well-established biochemical marker of cardiac hypertrophy.

120 e in a general population or have included a biochemical marker of current smoking.

121 IC1a disruption interfered with an important biochemical marker of depression, the ability of stress

122 s associated with MDD, myo-Inositol may be a biochemical marker of depressive mood symptoms across di

123 tidepressant-induced behaviors and on p11, a biochemical marker of depressive-like states and antidep

124 D-dimer levels may be useful as a potential biochemical marker of disease activity in certain cutane

125 mmonia, and a significant (P<0.02) resolving biochemical marker of liver injury that did not improve

126 ression of the immediate early gene c-fos, a biochemical marker of neuronal activation, in the NRM of

127 otein, pulmonary myeloperoxidase activity (a biochemical marker of neutrophils), and the chemokine ma

128 sal tissue myeloperoxidase (MPO) activity, a biochemical marker of neutrophils, significantly increas

129 ndicate that serum cotinine levels used as a biochemical marker of smoking status are correlated with

130 Free GGEL, a specific biochemical marker of Tgase activity, was markedly eleva

131 liver transplantation shows no difference in biochemical markers of acute organ injury and clinical o

132 and to identify the associated clinical and biochemical markers of AKI.

133 thophysiological changes over decades in CSF biochemical markers of Alzheimer's disease, brain amyloi

134 Survival, pancreatic inflammation, and biochemical markers of AP were measured.

135 gene disruption on various morphological and biochemical markers of apoptosis were then examined.

136 Biochemical markers of apoptosis, such as caspase activa

137 nifestation of a number of morphological and biochemical markers of apoptosis, we have shown that the

138 ration accompanied by the display of classic biochemical markers of apoptosis.

139 ctivation of CED3/ICE proteases are specific biochemical markers of apoptosis.

140 PET of the lumbar spine and measurements of biochemical markers of bone formation (bone-specific alk

141 Because biochemical markers of bone formation (serum osteocalcin

142 Changes in serum biochemical markers of bone metabolism were also assesse

143 und between histomorphometric parameters and biochemical markers of bone metabolism.

144 n changes in regional BMD, BMC, T scores, or biochemical markers of bone metabolism.

145 ribe the development of new radiological and biochemical markers of bone metastases.

146 condary measures were BMD at other sites and biochemical markers of bone remodeling.

147 s of effect, as measured by bone density and biochemical markers of bone remodeling.

148 Serum and urine biochemical markers of bone resorption and formation and

149 differentiation and activity, mediators, and biochemical markers of bone resorption and their use and

150 Biochemical markers of bone resorption were significantl

151 y measurement of bone mineral density (BMD), biochemical markers of bone resorption, and histomorphom

152 thopedics and osteoporosis have provided new biochemical markers of bone resorption, including oral b

153 Biochemical markers of bone turnover (serum osteocalcin,

154 This study used serially measured biochemical markers of bone turnover and bone density to

155 precision of (18)F-fluoride PET with that of biochemical markers of bone turnover assessed over 6 mo.

156 g alendronate or calcitriol on bone loss and biochemical markers of bone turnover during the second y

157 osphonate (MDP) are an alternative method to biochemical markers of bone turnover for investigating t

158 etically derived rates of bone turnover, and biochemical markers of bone turnover have increased our

159 Biochemical markers of bone turnover increased significa

160 Biochemical markers of bone turnover such as bone-specif

161 produced greater decreases from baseline in biochemical markers of bone turnover than did placebo (P

162 Changes in biochemical markers of bone turnover were also analysed

163 the correlation of bone mineral density and biochemical markers of bone turnover with vertebral frac

164 included changes in bone density of the hip, biochemical markers of bone turnover, and the incidence

165 n maternal bone mineral density (BMD) and on biochemical markers of bone turnover, and to determine t

166 neral density (BMD) of the spine and hip and biochemical markers of bone turnover.

167 Bone mineral density and biochemical markers of bone turnover.

168 dual-energy x-ray absorptiometry (DXA); and biochemical markers of bone turnover.

169 lyzed for calcium, calcitropic hormones, and biochemical markers of bone turnover.

170 pact on skeletal attributes, most notably on biochemical markers of bone turnover.

171 24 months after the drug transitions as were biochemical markers of bone turnover.

172 Biochemical markers of bone-turnover were measured at st

173 in renal transplant recipients with elevated biochemical markers of bone-turnover, suggesting that th

174 Raloxifene favorably alters biochemical markers of cardiovascular risk by decreasing

175 In addition to a range of biochemical markers of cartilage, bone and synovial tiss

176 etween the SCWs and previously characterized biochemical markers of cell-cycle progression.

177 mitted by mobile phones could induce various biochemical markers of cellular damage including reactiv

178 ift work impaired spatial memory and altered biochemical markers of cerebral cortical protein synthes

179 t liver transplantation, tacrolimus use, and biochemical markers of cholestasis after liver transplan

180 different levels of biological organization: biochemical markers of defense and damage, biomarkers of

181 Although some biochemical markers of differentiating ectoderm, mesoder

182 However, unlike clinical or biochemical markers of disease activity, psychological h

183 Biochemical markers of disease allow clinicians to monit

184 reatment in 3 patients and were analyzed for biochemical markers of disease burden.

185 Experimental outcomes included biochemical markers of disease severity.

186 were blood pressure, plasma renin, and other biochemical markers of diuretic action.

187 in the high-normal range, novel genetic and biochemical markers of elevated cardiorenal risk, and th

188 , Sequential Organ Failure Assessment score, biochemical markers of end organ dysfunction, and invasi

189 protein levels and raised concentrations of biochemical markers of endothelial and macrophage activa

190 hat abnormalities in vascular reactivity and biochemical markers of endothelial cell activation are p

191 Biochemical markers of endothelial function were also un

192 Biochemical markers of endotoxaemia, inflammation, and i

193 efore, a dose of U0126 sufficient to inhibit biochemical markers of ERK signaling in hippocampus does

194 The natriuretic peptides are biochemical markers of heart failure (HF) severity and p

195 t also reduced hepatic oxidative stress, and biochemical markers of hepatic inflammation and injury.

196 mice significantly reduced histological and biochemical markers of hepatic injury.

197 siological makers of autonomic function, and biochemical markers of HPA-axis activity; inflammatory p

198 ylate to 2,3- and 2,5-dihydroxybenzoic acid, biochemical markers of hydroxyl radical generation.

199 ed the cell size with enhanced expression of biochemical markers of hypertrophy, concomitant with ele

200 lator-free days and organ-failure-free days, biochemical markers of inflammation and fibroproliferati

201 Biochemical markers of inflammation such as C-reactive p

202 The biochemical markers of inflammation were raised in most

203 A-AION was based on expert interpretation of biochemical markers of inflammation, temporal artery bio

204 ed by changes in both inflammatory cells and biochemical markers of inflammation.

205 hrocyte sedimentation rate are commonly used biochemical markers of inflammatory disease.

206 udy 24-h urinary excretion data were used as biochemical markers of intakes of sodium, potassium, and

207 respective proteins are useful quantitative biochemical markers of intrauterine exposure to Hg0, a p

208 ing the functional recovery of the graft and biochemical markers of IRI.

209 Here, we analyse genetic association data on biochemical markers of iron status from 11 European-popu

210 ded gait function, compartment pressure, and biochemical markers of ischemia-reperfusion injury.

211 Biochemical markers of JSW included markers associated w

212 tment also improved cardiac function and the biochemical markers of kidney and liver damage.

213 ed with dual-energy x-ray absorptiometry and biochemical markers of liver and bone function in patien

214 ons between retinyl ester concentrations and biochemical markers of liver dysfunction in a nationally

215 atment, has demonstrated positive effects on biochemical markers of liver function.

216 rate, blood pressure, oxygen saturation, and biochemical markers of lung inflammation were not differ

217 These biochemical markers of macrophage activation states woul

218 es in levels of IL-33, type 2 cytokines, and biochemical markers of mast cell and platelet activation

219 Biochemical markers of metabolic health and 236 proteins

220 included determining the association between biochemical markers of methanol poisoning and final VA.

221 To examine this, we characterized biochemical markers of mineral metabolism, examined bone

222 at simultaneously included many clinical and biochemical markers of mortality risk.

223 trophin-deficient mdx mice, histological and biochemical markers of myonecrosis and regeneration are

224 study also evaluated other histological and biochemical markers of NASH and fibrosis, and safety.

225 and could be correlated with histologic and biochemical markers of neurologic sequelae.

226 g were significantly associated with several biochemical markers of obesity and CVD risk.

227 Biochemical markers of organ damage, liver NAD+/NADH (in

228 Biochemical markers of organ function were obtained.

229 l or near normal Histologic Damage Score and biochemical markers of organ injury.

230 on and poly(ADP-ribose) formation, which are biochemical markers of PARP-1 activation, were also bloc

231 e clinical outcome and may serve as valuable biochemical markers of prognosis.

232 (HR, 2.31; 95% CI, 1.72-3.10; P < .001), and biochemical markers of severe cholestasis (bilirubin >=1

233 to 400 microg/L, indicating that traditional biochemical markers of storage iron in patients with ane

234 Here, we used biochemical markers of synaptic plasticity in combinatio

235 cell line exhibits several morphological and biochemical markers of terminal epidermal differentiatio

236 and eIF2alpha phosphorylation represent two biochemical markers of the effects induced by N-(3-oxo-a

237 The effect of SD208 on the expression of key biochemical markers of the fibrotic phenotype was compar

238 Biochemical markers of the GH-insulin-like growth factor

239 eatures, thyroid function, physiological and biochemical markers of thyroid hormone action, and THRA

240 carotenoids have been proposed as integrated biochemical markers of vegetable, fruit, and synthetic s

241 The response of osteocalcin and other biochemical markers of vitamin K status to diets formula

242 d is up-regulated by lipopolysaccharide, all biochemical markers of ZIP8 or ZIP14 activity.

243 Nevertheless, advances in both imaging and biochemical markers offer potential for diagnosis and as

244 rketing authorization for new drugs based on biochemical markers on the condition that long-term, ran

245 Bone pain, analgesic use, bone biochemical markers, performance status, quality of life

246 immunohistochemistry after injection of the biochemical marker pimonidazole or by staining for caspa

247 s in bone, measurable disease, symptoms, and biochemical markers (primarily PSA levels), rather than

248 The differences in biochemical marker profiles associated with osteophytes

249 ce of disease relapse restricted to a rising biochemical marker, prostate-specific antigen (PSA), ind

250 Electrophysiologic function and the mucosa biochemical marker recovered within 3 days in the jejunu

251 and platelet counts and dysregulation of key biochemical markers related to hepatic/renal function, a

252 of a variety of clinical signs and symptoms, biochemical marker screening, electron transport chain e

253 d to establish whether the combined panel of biochemical markers showed a stronger association with i

254 Fourteen biochemical markers showed significant associations with

255 les may have storage or lytic functions, but biochemical markers specific for the tonoplasts of funct

256 ired for the expression of morphological and biochemical markers specific to each of these stages.

257 thousand-kernel weight, in conjunction with biochemical markers such as chlorophyll content, proline

258 junction protein ZO-1), gain of mesenchymal biochemical markers, such as fibronectin, and acquisitio

259 challenge since it does not have a practical biochemical marker that can be followed or quantified.

260 now well-recognized alterations of neuronal biochemical markers that accompany tissue destruction re

261 rent projection and by a number of classical biochemical markers that are distributed in a pattern of

262 ET also offers the ability to quantify other biochemical markers that can yield additional useful dia

263 colocalization of CaMKII with several other biochemical markers that identify specific neuron classe

264 Alternatively, concentrations of surrogate biochemical markers that reflect the metabolic function

265 cytoplasm ratio and lack of lineage-specific biochemical markers; the effect of 17 beta-estradiol on

266 yl-diacylglycerol as a functionally relevant biochemical marker to define treatment conditions.

267 d mother-infant infections, can be used as a biochemical marker to discriminate them from H. influenz

268 side-mediated topoisomerase-II cleavage as a biochemical marker to map centromeric DNA on all 14 para

269 r, phosphorylated ERK has not been used as a biochemical marker to monitor pharmacology of these biom

270 and consumer traits via easily quantifiable biochemical markers to aid gene discovery and functional

271 nd memory CD4 T cells that identify critical biochemical markers to distinguish these subsets.

272 Consequently, these enzymes may provide the biochemical markers to enable earlier diagnosis of ALS a

273 diagnosis from the Correlating Outcomes with biochemical Markers to Estimate Time-progression (COMET)

274 of the COMET-IPF (Correlating Outcomes with Biochemical Markers to Estimate Time-Progression in Idio

275 tients from COMET (Correlating Outcomes with Biochemical Markers to Estimate Time-Progression in IPF)

276 By combining specific panels of biochemical markers to form factors, the association of

277 anti-BPEP antibodies and antibodies to other biochemical markers to label B. napus and Arabidopsis th

278 The use of biochemical markers to monitor bone-modifying agent use

279 The ability of biochemical markers to predict adverse outcomes in both

280 BMB are hampered by difficulties with using biochemical markers to quantify the relative rates of bo

281 itional parameters (e.g., genetics and novel biochemical markers) to develop further the PIRO stratif

282 Biochemical markers, treatment modalities, length of sta

283 (SPKTx) is currently assessed by nonspecific biochemical markers, typically amylase or lipase.

284 For comparison, the precision of the biochemical markers was 10% (7%-15%), 18% (13%-27%), and

285 dynamic changes of the proteome and several biochemical markers was connected for the first time wit

286 Correlation between SUVmax of tumors and biochemical markers was evaluated.

287 Twenty serum and urinary biochemical markers were analyzed in 119 patients with p

288 dings from clinical examination, and adrenal biochemical markers were available for all patients.

289 Biochemical markers were evaluated through the first 24

290 Histologic and biochemical markers were measured in liver tissues and p

291 Several biochemical markers were measured.

292 asurements and blood collection for clinical biochemical markers were performed in overnight-fasted s

293 oimmune hepatitis, pruritus or cirrhosis) or biochemical markers were significantly associated with m

294 In conclusion, HbA1c is a useful biochemical marker when predicting the time to diagnosis

295 independent of clinical characteristics and biochemical markers why HRQOL should be considered as an

296 Biochemical markers will confirm the radiological diagno

297 udies have unveiled numerous correlations of biochemical markers with age and age-related diseases, w

298 Integrating these objective biochemical markers with temporal mapping of teeth enabl

299 complex disease with a range of genetic and biochemical markers within and among tumors, but a gener

300 RNA is a key biochemical marker, yet its chemical instability and com